CC
ENFN

Clearline Capital’s Enfusion, Inc. ENFN Stock Holding History

Clearline Capital’s Portfolio ENFN Stock Details ENFN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-107,358
Closed -$1.11M – 133
2024
Q4 		$1.11M Sell
107,358
-137,787
-56% -$1.33M 0.15% 78
2024
Q3 		$2.33M Buy
245,145
+61,971
+34% +$535K 0.1% 93
2024
Q2 		$1.56M Sell
183,174
-70,738
-28% -$647K 0.04% 102
2024
Q1 		$2.35M Buy
253,912
+60,556
+31% +$533K 0.11% 79
2023
Q4 		$1.88M Sell
193,356
-256,286
-57% -$2.39M 0.11% 74
2023
Q3 		$4.03M Buy
+449,642
New +$4.27M 0.35% 70

Other funds holding ENFN

FMC
FTV Management Company San Francisco, California $541M AUM 34.37% 1-Year Est. Return
IC
Iconiq Capital San Francisco, California $4.46B AUM 22.86% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $1.67B AUM 7.53% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
AAM
Alpine Associates Management Palm Beach, Florida $1.7B AUM 97.55% 1-Year Est. Return
LECM
Lead Edge Capital Management New York $408M AUM 4.05% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
New York State Common Retirement Fund
New York State Common Retirement Fund Albany, New York $71.6B AUM 29.66% 1-Year Est. Return

Clearline Capital's ENFN Position: Q1 2025 in Review

Clearline Capital sold out of Enfusion, Inc. (ENFN) in Q1 2025, closing a stake of 107,358 shares — an estimated $1.11M sold.

Clearline Capital first reported a position in ENFN in Q3 2023 and held it in 6 quarters. The position peaked at $4.03M in Q3 2023. 132 funds tracked by Wall St. Rank hold ENFN as of Q1 2025.

  • Clearline Capital reported no remaining Enfusion, Inc. position as of Q1 2025 after selling out during the quarter.
  • Clearline Capital sold 107,358 Enfusion, Inc. shares in Q1 2025, an estimated $1.11M.
  • Clearline Capital first reported a position in Enfusion, Inc. in Q3 2023 and held it in 6 quarters.
  • Clearline Capital's Enfusion, Inc. position peaked at $4.03M in Q3 2023.
  • 132 funds tracked by Wall St. Rank held Enfusion, Inc. as of Q1 2025.

Based on Clearline Capital's 13F filing for Q1 2025, filed 16 May 2025.